Results 31 to 40 of about 86,609 (293)

Restenosis of Drug-Eluting Stents.

Circulation. Cardiovascular Interventions, 2019
Despite on-going evolution and iteration of drug-eluting stent (DES) technology, the prevalence of in-stent restenosis (ISR) remains relatively unchanged, encompassing ≈10% of percutaneous coronary interventions.
Evan Shlofmitz, M. Iantorno, R. Waksman
semanticscholar   +1 more source

The preoperative triglyceride-glucose index has a positive effect on predicting the risk of short-term restenosis after carotid artery stenting: a retrospective cohort study

Frontiers in Neurology, 2023
BackgroundIncreasing evidence suggests that insulin resistance is linked to cardiovascular disease and atherosclerosis. The triglyceride–glucose (TyG) index has proven to be a convincing marker to quantitatively evaluate insulin resistance.
Shan-shan Zhao, Zhen-zhen Jiang, Bo Wei, Jian-bo Zhu, Xia-tian Liu   +4 more
doaj   +1 more source

Length of carotid stenosis predicts peri-procedural stroke or death and restenosis in patients randomized to endovascular treatment or endarterectomy. [PDF]

, 2013
BACKGROUND: The anatomy of carotid stenosis may influence the outcome of endovascular treatment or carotid endarterectomy. Whether anatomy favors one treatment over the other in terms of safety or efficacy has not been investigated in randomized trials.
Angus-Leppan, H., Ashleigh, R. J., Baskerville, P., Beard, J., Beard, J. D., Beard, Jonathan D., Belloni, G., Birch, P. A., Bladin, C. F., Bland, J. M., Bleakley, T., Bogousslavsky, J., Bonati, Leo H., Boza, F., Bradbury, A., Brown, M. M., Brown, M. M., Brown, M. M., Brown, Martin M., Buckenham, T., Buckenham, T., Buckenham, T., Burrett, J., Butler, P., Chamorro, A., Cleveland, T. J., Clifton, A., Clifton, A., Clifton, A., Clifton, Andrew, Collie, D., Colquhoun, D., Colquhoun, D., Coward, L., Cox, T., Crawley, F., Crawley, F., Crowther, J., Davis, S., Dick, J., Dobinson, P., Dobson, Joanna, Dobson, M., Donnan, G. A., Doyle, C., Duddy, M., E Pringle, C., Earnshaw, J. J., Ederle, Jörg, Enevoldson, T. P., Engelter, Stefan, Featherstone, R., Featherstone, Roland L., Fell, G., Ferro, J., Fitt, G., Frankel, F., Fraser, S., Fuller, G. N., Gaines, P. A., Gaines, Peter A., Garcia Rodríguez, J. L., Gerraty, R., Gholkar, A., Gil Peralta, A., Gilling-Smith, G., González Marcos, J. R., González, A., Goodman, M. A., Grahovac, S., Hafner, B., Halpin, S., Hankey, G. J., Harris, P., Harrison, M., Heafield, M. T.E., Heather, B., Heineman, J., Holder, S., Hope, C., Hope, D. T., Hughes, J., Jefferson, D., Jeffrey, M., Khangure, M. S., Kirsch, E. C., Knight, S., Lane, I., Lawrence-Brown, M. M., Leopold, P. W., Linto, J., Loosemore, T., Lyrer, P. A., Malms, J., Markus, H., Markus, H., Markus, Hugh S., Mayol Deya, A., McAuliffe, W., McCabe, D. J.H., McCabe, D. J.H., McCollum, C. N., McConachie, N., Mendelow, A. D., Mitchell, P., Molloy, J., Morrish, W., Murie, J. A., Naughten, A., Nixon, T., O'Neill, P., Pageau, N., Pereira, A., Pereira, A., Porta, M., Poskitt, K., Prendergast, F. J., Radley, A., Rauno, J., Reiher, L., Rem, J. A., Riambau, V., Richard, D. M., Richards, S., Rogers, J., Rogers, J., Royle, J., Ruckley, C. V., Sandercock, P. A.G., Sandercock, P. A.G., Sandercock, Peter, Schultz, D., Sellar, R. J., Siebler, M., Siennarine, K., Silver, L., Sivaguru, A., Smith, D., Stewart-Wynne, E. G., Taylor, R. S., Taylor, R. S., Tognoni, G., Tottle, A. J., Uske, A., Vazquez, F., Venables, G. S., Venables, Graham S., Vila, N., Vohra, R. K., Walls, T. J., Wardlaw, J., Warlow, C. P., Wenzel, S., Wiles, M., Wood, A. M.   +154 more
core   +2 more sources

Hyperhomocysteinemia and recurrent carotid stenosis

BMC Cardiovascular Disorders, 2008
Background Hyperhomocysteinemia has been identified as a potential risk for atherosclerotic disease in epidemiologic studies. This study investigates the impact of elevated serum homocysteine on restenosis after carotid endarterectomy (CEA). Methods In a
Liewald Florian, Hillenbrand Andreas, Hillenbrand Renata, Zimmermann Julian   +3 more
doaj   +1 more source

Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment.

Journal of Thoracic Disease, 2016
The lumen diameter reduction after percutaneous coronary intervention (PCI) is well known as "restenosis". This phenomenon is due to vessel remodeling/recoil in case of no-stent strategy or, in case of stent employ, "neointimal proliferation" that ...
D. Buccheri, D. Piraino, G. Andolina, B. Cortese   +3 more
semanticscholar   +1 more source

A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]

, 2016
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L., Kennedy, Simon, McCormick, Christopher, Mullen, Alexander B., Wadsworth, Roger M.   +4 more
core   +2 more sources

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

European Heart Journal, 2015
Modern-day stenting procedures leverage advances in pharmacotherapy and device innovation. Patients treated with contemporary antiplatelet agents, peri-procedural antithrombin therapy and new-generation drug-eluting stents (DES) have excellent outcomes ...
R. Byrne, M. Joner, A. Kastrati
semanticscholar   +1 more source

In Stent Restenosis Predictors after Carotid Artery Stenting

Stroke Research and Treatment, 2010
Purpose. The long-term efficacy of carotid artery stenting is debated. Predictors of stent restenosis are not fully investigated. Our aim was to assess the incidence of long term restenosis after CAS and to identify some predictors of restenosis. Methods.
Mirco Cosottini, Maria Chiara Michelassi, Walter Bencivelli, Guido Lazzarotti, Silvia Picchietti, Giovanni Orlandi, Giuliano Parenti, Michele Puglioli   +7 more
doaj   +1 more source

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study

Cardiovascular Diabetology, 2019
BackgroundIn patients with Normal Glucose Tolerance (NGT) some causes of ischemic heart disease (IHD) were not completely investigated. The role both of metabolic milieu and adipokines in IHD progression was not fully investigated.
F. C. Sasso, P. Pafundi, R. Marfella, P. Calabrò, F. Piscione, F. Furbatto, G. Esposito, R. Galiero, F. Gragnano, L. Rinaldi, T. Salvatore, M. D'Amico, L. Adinolfi, C. Sardu   +13 more
semanticscholar   +1 more source

Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]

, 2011
<p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H., Biondi, G., Colombo, A., Di Lauro, M.V., Gordon, P., Grassia, G., Guglielmotti, A., Ialenti, A., Kennedy, S., Maddaluno, M., Maffia, P.   +10 more
core   +1 more source